22 May 2013
Keywords: Novartis, Teva, Russia, RT-Biotechprom, Manufacturing facilities, Investment
Article | 05 July 2012
Swiss drug major Novartis (NOVN: VX) has signed an agreement with RT-Biotechprom, one of Russia’s largest pharmaceutical and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2012
21 May 2013
© 2013 thepharmaletter.com